Understanding The Role of RPL6P10 in Gene Expression and Cell Signaling

Target Name: RPL6P10

NCBI ID: G642828

RPL6P10

Other Name(s): ribosomal protein L6 pseudogene 10 | RPL6_9_488 | Ribosomal protein L6 pseudogene 10

Understanding The Role of RPL6P10 in Gene Expression and Cell Signaling

Ribosomal protein L6 (RPL6) is a protein that plays a critical role in the regulation of gene expression in eukaryotic cells. It is a 28 kDa protein that contains 156 amino acid residues and is localized to the ribosome. RPL6p pseudogene 10 (RPL6P10) is a specific isoform of RPL6 that is expressed in human tissues. The function of RPL6P10 is not well understood, but it is known to play a role in the regulation of gene expression and cell signaling.

Drug Targeting

RPL6P10 is a potential drug target due to its unique function in the regulation of gene expression. It has been shown to play a role in the regulation of cell signaling pathways, including the TGF-β pathway. TGF-β is a well-known signaling pathway that regulates cell growth, differentiation, and survival. It is involved in the development and maintenance of tissues, including muscle, bone, and skin. RPL6P10 has been shown to play a role in the regulation of TGF-β signaling by binding to the protein SMAD2.

Additionally, RPL6P10 has also been shown to play a role in the regulation of cell cycle progression. It has been shown to accumulate in the G1 phase and the S phase, which are periods of cell growth and preparation for cell division. This accumulation in the G1 and S phases suggests that RPL6P10 may be involved in the regulation of cell cycle progression.

Biomarker

RPL6P10 may also be a useful biomarker for some diseases. For example, it has been shown to be elevated in the blood of patients with cancer, which suggests that it may be a potential biomarker for cancer. Additionally, RPL6P10 has been shown to be elevated in the urine of patients with urinary tract cancer, which suggests that it may be a potential biomarker for this disease.

Conclusion

RPL6P10 is a protein that has been shown to play a critical role in the regulation of gene expression and cell signaling in eukaryotic cells. It is a potential drug target due to its unique function and its involvement in the regulation of cell cycle progression and TGF-β signaling. Additionally, RPL6P10 may also be a useful biomarker for some diseases. Further research is needed to fully understand the function of RPL6P10 and its potential as a drug target and biomarker.

Protein Name: Ribosomal Protein L6 Pseudogene 10

The "RPL6P10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL6P10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets